HOME - Companies - News
 
 
26 July 2021

Bioceramics to reach $23B by 2031: Fact.MR

Katherine E. Pfaff


According to a survey by Fact.MR, market research and competitive intelligence company, the bioceramics market is expected to grow at a CAGR of 7% from 2021 to 2031. The increase marks a 1.5 times change over the period, with the market value forecast to reach $23 billion in a decade. The market was valued at $14 billion in 2020. 

The US is anticipated to demonstrate the highest growth and is considered the largest geographical segment based on sales. In 2020, the US market reached an estimated $4 billion. 

The increase is expected in part as dental disease, and musculoskeletal diseases are reported at increasing rates. Bioceramics are expected to be used as the basis for orthopedic implants. Dental implants are expected to utilize bioceramics in devices, including bridges, crowns, dentures, and bristles. Growth within the market is also expected as applications for bioceramics increase, including orthopedics and dentistry.



Source: https://www.prnewswire.com/news-releases/bioceramics-use-as-lightweight-and-flexible-material-for-orthopedic-implant-to-gain-pace-at-7-by-2031-factmr-survey-301328673.html

Related articles

Bioceramics are ceramic compounds obtained both in situ and in vivo, by various chemical processes.


Endodontics     21 August 2024

Bioceramics in Endodontics

Bioceramics are materials which include Alumina, Zirconia, Bioactive glass, Glass ceramics, Hydroxyapatite, resorbable Calcium phosphates, among others.


The Congress will highlight an impressive roster of expert speakers and researchers in the field of bio ceramics and metal-free implant dentistry. Lectures and workshops have been selected with the...


Read more

Kerr Dental’s ZenSeal is a calcium silicate-based sealer that features optimal flowability to adhere tightly to dentin and gutta-percha in simple and complex root canal cases, incr


Dentsply Sirona’s premier clinical education event equips dental professionals with practical, evidence-based strategies to help achieve more predictable outcomes, enhance the pati


Recognition for a C$3.3 billion take-private that prioritized dentist participation and positions Dentalcorp to accelerate growth across North America


Plemons, clinical professor in periodontics and the inaugural executive director of external affairs at Texas A&M College of Dentistry, was recently selected as an at-large nominee


This peer-reviewed endodontics article summarizes clinical evidence from Journal of dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


 
 
 
 

 
 
 
 

Most popular

 
 

Events